CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

Another MAC has agreed to cover the use of these advanced technologies to evaluate patients for signs of coronary artery disease. 

The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

The new AUC document was designed to help care teams know when and how to perform imaging-based cardiovascular evaluations on patients undergoing nonemergent, noncardiac surgery.

An AI-aided way has emerged to confidently select dementia patients who are likely to benefit from amyloid-PET imaging while appropriately de-selecting patients for whom the costly exam would probably be unhelpful.  

Advanced imaging equipment using ionizing radiation enters the global market at the rate of one new technology every five years.

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.